Home > Animal Health & Nutrition > Veterinary Pharmaceuticals > Pet Cancer Therapeutics Market
Some of the key players in the pet cancer therapeutics market are
These firms are engaging in new product R&D programs to achieve a competitive edge in the business. For instance, in June 2022, biopharmaceutical firm, Boehringer Ingelheim, along with CarthroniX, a developer of small molecule-based therapies for aging-related and degenerative diseases, announced a research partnership to create small molecule therapeutics in canine oncology. This innovation is likely to aid the company in expanding the Animal Health division of Boehringer Ingelheim and present an innovative approach to canine cancer treatment.